Group items tagged

The Company Chemists' Association (CCA)'s analysis on permanent closures of community pharmacies in England showed that there has been a net loss of 670 pharmacies between 2015 and 2022. The analysis highlighted that 37 per cent of permanent closures of pharmacies and GP practices have occurred in the 20 per cent most deprived parts of England. Current trends indicate that primary care 'cold spots' could soon emerge - areas where there is significantly reduced or inadequate access to a pharmacy or a GP. The CCA's analysis shows that some of the most deprived neighbourhoods concentrated in the North West, the West Midlands and Yorkshire have faced the highest losses of local pharmacies and GP practices since 2015. It demonstrates that the trend of permanent closures amongst pharmacies and GP practices is worsening. Moreover, this burden is likely to be felt unevenly with permanent closures occurring disproportionately in areas of high deprivation. Without action, deprived communities, where need is typically greater, may no longer be able to access the GP and pharmacy services they require.

Major Highlights of the Sugar Beet Seeds Market report study: A detailed look at the global Sugar Beet Seeds Industry The report analyzes the global Sugar Beet Seeds market and provides its stakeholders with significant actionable insights The report has considered all the major developments in the recent past, helping the users of the report with recent industry updates The report study is expected to help the key decision-makers in the industry to assist them in the decision-making process The study includes data on market intelligence, changing market dynamics, current and expected market trends, etc. The report comprises an in-depth analysis of macroeconomic and microeconomic factors affecting the global Sugar Beet Seeds market Market Ecosystem and adoption across market regions Major trends shaping the global Sugar Beet Seeds market Historical and forecast size of the Sugar Beet Seeds market in terms of Revenue (USD Million) Recent industry development and consumer preference trends Competitive Landscape and player positioning analysis for the global Sugar Beet Seeds market Key products and solution offerings by major players and business strategies adopted Recommendations for new market entrants and current players operating in the market space Analysis of niche and potential segments (type, application, and regions/countries) anticipated to observed promising growth Key challenges faced by operating players in the market space Analysis of major risks associated with the market operations Get FREE PDF Copy @ https://www.marketresearchstore.com/sample/sugar-beet-seeds-market-794502?utm_source=diigo.com-VPL&utm_medium=Varsha

The Veterinary Software Report Provide SWOT analysis to understand Strengths, Weaknesses, Opportunities, and Threats of the Veterinary Software industry along with competitive Analysis. Along with, analysis of upstream raw materials and downstream consumers are also conducted in Veterinary Software research study. Global Veterinary Software market influences various other factors such as globalization, improvements in trade and income, and commercialization to enhance extensive growth.

Black Haircare Market Report covers key strategic developments of the market including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the black haircare market on a global and regional basis. To give the users of this report a comprehensive view on the black haircare market competitive landscape and analysis of Porter's Five Forces model for the market are included in the report. The study encompasses market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The National Pharmacy Association (NPA) has raised the alarm that many community pharmacies are facing losses on NHS prescriptions due to the "broken" funding system. An analysis of prescription drug prices by the NPA revealed that pharmacies are being underpaid by the NHS by up to £75 a pack for common medicines, resulting in losses of thousands of pounds each month. The analysis report released today (16 October) shows the government reimburses £18.06 for a 56-tablet pack of Amantadine, a drug used to treat Parkinson's symptoms. However, the market price of the drug is £94.05 per pack, leading to a loss of £75.99 per 56-tablet pack for pharmacies-amounting to a shortfall of over £1 per tablet. In some instances, NHS funding covers only one-fifth of the cost that pharmacies have to pay for medicines, according to new figures from the NPA.

A recent analysis conducted by the Company Chemists' Association (CCA) has revealed stark disparities in patient engagement with the Pharmacy First service across the country, likening the pattern to a 'patchwork quilt'. It indicated that patients in the highest-performing Integrated Care System (ICS) received seven times more Pharmacy First consultations than those in the lowest-performing regions. As of April 21, more than 3,000 CCA member pharmacies had delivered 126,484 Pharmacy First consultations since the programme's launch. However, the analysis found significant regional variations, with nearly 13,000 consultations completed in the North East and North Cumbria ICS, while only 948 were completed in Gloucestershire ICS. The CCA calculated that if every ICS had as many consultations as the highest-performing ICS, there would have been an additional 600,000 Pharmacy First consultations nationwide.

Locate a Locum's analysis has found that there has been around 14 per cent rise in rate of locum pharmacists in a year. The report said: "Post-covid locum pharmacist rates remain at an all-time high because of a variety of internal and external factors, including continued strong local and regional demand for pharmacist services, which is more acute in some areas, and some persistent last-minute or unplanned booking activity among pharmacies." The study is based on an analysis of more than 30,000 locum pharmacist shifts booked on the Locate a Locum platform between April 1 and June 30 this year and compared with the same period in 2021. "Locum pharmacy rates are a hot topic within the industry and this interest looks likely to continue, particularly given our latest analysis of rising prices and our assessment that if current market conditions persist, they will continue to increase into 2023," said Locate a Locum founder and chief executive Jonathan Clarke.

Biological Safety Cabinet Research reports cover detailed competitive outlook including the market share and company profiles of the key participants operating in the Global market. The Biological Safety Cabinet market report provides an in-depth overview of Product Specification, technology, product type and production Analysis considering major factors such as Revenue, Cost, Gross and Gross Margin

The UK has witnessed a nearly 50 percent increase in pharmacy closures this year compared to the same period in 2023, which was already considered the worst year in recent memory. A new analysis by the National Pharmacy Association (NPA) revealed that 177 pharmacies closed their doors between January and April 2024, compared to 116 in the same period last year. This is the equivalent of 10 local pharmacies shutting down every week. Analysis of NHS figures by the NPA showed that 403 pharmacies closed their doors last year, nearly five times higher than the number that closed in 2022. Since 2017, over 1,400 pharmacies have shut down across the UK. Rising costs and declining real terms funding have led to the fastest rate of closures in decades, said the NPA, highlighting that "real terms funding has decreased by 40 per cent over the last decade."

The new Labour government has pledged to deliver an extra 40,000 NHS appointments, operations and diagnostics every week, equivalent to two million a year, to tackle the ongoing waiting list crisis. It aims to ensure that 92 per cent of patients start routine hospital treatment within 18 weeks by the end of this parliament - a target that has not been met for nearly a decade. However, a new analysis by healthcare consultancy CF (Carnall Farrar) and the NHS Confederation has revealed that these extra appointments alone will not be enough to achieve the 18-week Referral To Treatment (RTT) target by 2028/29. The study estimates that 40,000 extra appointments per week would deliver only about 15 per cent of the additional activity required to hit the 18-week target, assuming demand continues to grow at current rates and care delivery remains unchanged. While the report acknowledged that increasing capacity is a positive step, it stresses that further reforms and transformations in care pathways are necessary to bridge the gap.

Rural areas have been hit the hardest by a wave of pharmacy closures over the past two years, according to a new analysis by the National Pharmacy Association (NPA). The analysis published today revealed that nearly nine in ten council areas across England have suffered the loss of vital pharmacies and warned that many rural areas risk becoming "pharmacy deserts" if the current closure rates continue. Additionally, the NPA, which represents independent community pharmacies, warned that England faces a significant risk to the availability of essential medicines if "a decade of underfunding and closures" is not addressed. It is calling on the government to reverse the 40 per cent real-terms cuts to community pharmacy budgets over the past decade, which have led to the closure of over 1,500 pharmacies and forced many others to reduce their opening hours. NPA Chief Executive, Paul Rees said: "These shocking statistics show how a growing number of areas are at risk of becoming pharmacy deserts, with people in rural towns and villages having to travel longer and longer distances to get hold of the medication they need.

More cancers are being detected earlier in England, thanks to a major drive by the NHS encouraging people, particularly those at higher risk due to hereditary or lifestyle factors, to come forward for potentially life-saving screenings. According to a new NHS analysis, early cancer diagnosis in England has reached its highest level ever. The NHS data of the most common cancers, including breast, prostate, and lung cancer, shows that almost three in five patients are now being diagnosed at stages one or two, when the cancer is more treatable. More than 58 per cent of all common cancers (206,038) diagnosed between September 2023 and August 2024 were identified at an early stage. This marks a 2.7 percentage point improvement compared to pre-pandemic levels, equating to an estimated 7,000 more patients being diagnosed at an early stage. The NHS has introduced initiatives like the Targeted Lung Health Check (TLHC) and Liver Health Programmes to detect cancers earlier.

Advanced technology is its flexibility. wheelchair provide some technologies can be used at home like power wheelchair,hearing aids,moped in the workplace, and in school, expanding the ability of the user to participate in various spheres of daily life. Augmentative and alternative communication technology is one such area of IT progress.where we use of hearing aids for communication and It includes inventions such as speech-generating devices, Teletypewriter devices, adaptive pointing devices to replace computer mouse devices, and many others. The following impairments are some of the disabilities that affect communications and technology access, as well as many other life activities: communication disorders: hearing impairments: visual impairments: mobility impairments: a learning disability or impairment in mental functioning. Each kind of disability requires a different kind of accommodation like dumb person use hearing aids and this may require analysis by a medical specialist and in medical,hospital we can see that disable person use health care product, an educational specialist or a job analysis when the impairment requires accommodation. Assistive technology is the creation of a new device that assists a person in completing a task that would otherwise be impossible,we take some example if some one not walk but now days they can do by use of power wheelchair,basic wheelchair,commode wheelchair. Some examples include new computer software programs, and inventions such as assistive listening devices, including hearing aids, and traffic lights with a standard color code that enables colorblind individuals to understand the correct signal,mode also useful for wondering in one way to another way. now we talk about adaptive technology so adaptive technology is the adaptation,modification, of existing devices, methods, or the creation of new uses for existing devices, to enable a person to complete a task. Examples include the use of remote control

India will make tests mandatory for cough syrups before they are exported, a government notice showed on Tuesday, after Indian-made cough syrups were linked to the deaths of dozens of children in Gambia and Uzbekistan. Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, the government said in a notice dated May 22 and shared by the health ministry on Tuesday. India's $41 billion pharmaceutical industry is one of the biggest in the world but its reputation was shaken after the World Health Organization (WHO) found toxins in cough syrups made by three Indian companies. Syrups made by two of these companies were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year. "Cough syrup shall be permitted to be exported subject to the export sample being tested and production of certificate of analysis," said the notice issued by the trade ministry. The health ministry did not immediately respond to a query on whether testing would be required for cough syrups sold in the domestic market.

Adding to the growing evidence of global medicine shortages, a new study has revealed that the European generic medicines market is "not in shape" to help Europe meet its public health priorities. In the past decade, the rate of generic medicines withdrawals has risen by 12 per cent, while there has been a three per cent decrease in the launch of generic products, as per Teva Pharmaceuticals' recent analysis of IQVIA data. Within the mental therapeutic area, seven per cent of generic products disappeared between 2013 and 2023, while there was a seven per cent decrease in the availability of generic cancer medicines in just six years (2017-2022). These medicines were listed on the Union List of Critical Medicines to help avoid potential shortages, as the European Commission (EC) said this could cause "significant harm to patients and pose important challenges to health systems." While mature generic products constitute the majority of the List, they remain susceptible to withdrawals, despite containing products crucial for safeguarding Europe's public health, the Teva analysis report noted. Since 2013, the number of generic products for the treatment of schizophrenia and bipolar disorder has declined by 25 per cent, with Hungary and Bulgaria experiencing the biggest loss at 83 per cent and 58 per cent respectively.

The Government has been forced to intervene formally 50 times in the past two years to authorise the use of alternative drugs because of serious medicine shortages hitting patients, new analysis by the National Pharmacy Association (NPA) has found today. 78 per cent of all Serious Shortage Protocols, produced by the Department of Health and Social Care (DHSC) due to medicine shortages, were issued in 2022/24 - more than three times the rate in the previous two years. The NPA, which represents independent community pharmacies in the UK, is warning that shortages are leading to pharmacists having to increasingly turn patients needing vital medication away. Analysis by the NPA of the NHS's Serious Shortage Protocols (SSPs) issued to pharmacies and other providers over the last five years has found that: The number of SSPs issued in the last two years is 3.5 times higher than in the previous two years.

Expressing apprehension over the concerning decline in the nursing workforce, Sir Julian Hartley, CEO of NHS Providers, urged the forthcoming government to bolster investment in nursing education and enhance support for student nurses. Recent analysis from the Royal College of Nursing (RCN) has projected that the NHS Long Term Workforce Plan will fall short by 10,000 new nurses by 2025. Commenting on the RCN analysis, Sir Hartley underscored the critical importance of having an adequate number of nurses to ensure the delivery of safe, high-quality patient care. "Without enough nurses, the delivery of safe, high-quality patient care is compromised," he said. He cautioned that the predicted shortfall in nurses would exacerbate existing pressures on the NHS, resulting in long waiting times, delayed treatments and staff burnout.

The UK is far behind comparable nations in spending on medicines and community pharmacies, according to a new analysis by the National Pharmacy Association (NPA). Published today, the report highlights that Britain ranks among the worst countries in the Organisation for Economic Co-operation and Development (OECD) for access to pharmacies, with fewer pharmacies per 100,000 people than countries like Bulgaria, Latvia, Romania, Portugal, Spain, Turkey, France, and many others. On average, a UK pharmacy serves around 5,700 patients, far more than those in France (3,238 patients) and the Republic of Ireland (2,500 patients), where an average pharmacy caters to less than half the number of patients served in the UK. All comparable countries manage fewer patients per pharmacy. The NPA analysis also found that the UK spends less per capita on medicines than nations such as Australia, Ireland, Japan, the US, Spain, Germany, and Italy. Germany spends twice as much as the UK, while the US spends nearly three times more.

The Royal College of Nursing (RCN) has called on the UK government to invest in and reimagine learning disability nursing, as its analysis reveals parts of England risk becoming "learning disability nurse deserts," with student numbers collapsing across all regions and courses closing at an alarming rate. Over the past eight years, the number of acceptances onto learning disability nursing courses in England has dropped by 36 per cent, according to the RCN analysis. In 2024, not a single university in the South East offered the degree. Additionally, the number of learning disability nurses employed in the NHS in England has nearly halved since May 2010, as of July 2024. The RCN has warned that this crisis could leave vulnerable people without access to vital care. It noted that reforms to nursing education, including the removal of the nursing bursary and universal maintenance support for undergraduates, have particularly impacted learning disability nursing, a specialty that depends heavily on mature students.

Scottish Conservative MSP Stephen Kerr has slammed the SNP government for making taxpayers cover the cost of 'free' prescriptions for basic painkillers like paracetamol and ibuprofen on the NHS. An analysis conducted by Kerr, first reported in The Telegraph, revealed that the NHS Scotland pays as much as £8.53 per pack of paracetamol under its free prescription policy. Public Health Scotland data shows that nearly 2.5 million prescriptions for the common painkiller were issued in 2023-24, costing more than £14 million. Including an estimated £7 million to cover the pharmacy "dispensing fee", the total cost equates to £8.53 per prescription. In contrast, paracetamol can be purchased for as little as 37p in supermarkets. Similarly, Kerr's analysis found that ibuprofen-available over the counter for just 39p-cost the NHS £6.87 per prescription. Kerr condemned the costs as "beyond absurd," accusing the SNP of financial mismanagement.